They're running biotech like it's going out of style -- financials tomorrow. Needs more of a catalyst though than just "this trades near cash value" .. Ideally there's something coming down the pipe. I think 20m market cap is pretty low in a sector that is getting millions of dollar momentum.. they seem to be running them all to 100m market cap. So, I'll take half that. I'm not greedy